Prostate Cancer Test AU - geneType™
menu

Did you know that four key risk factors contribute to your prostate cancer risk?²

Your health starts with understanding your risk of developing disease.

This short video introduces geneType™ – A comprehensive risk assessment tool that helps you and your doctor make proactive, personalised decisions about screening and prevention. Learn how geneType™ looks beyond family history to give you a clearer picture of your true cancer and disease risk.

How often should you do a PSA screen?

PSA screening is an effective tool, but the choice to screen is left up to you and your health provider.¹

Have a more informed discussion with your doctor by knowing your holistic risk of prostate cancer.

The geneType™ patient

geneType™ for Prostate Cancer is appropriate for:

  • Men
  • Age 30 – 85 years
  • No known hereditary gene mutation e.g.  BRCA2

Uniquely powered to assess your risk

Get a clearer picture of your risk.

Make screening decisions that fit your needs.

Have questions? We have answers.

If your question is not shown here, please Contact us directly.

Will insurance cover this test?

No. At this time geneType™ is a self-pay test. However, you may use FSA/HSA to pay for the test.

Know your risk of prostate cancer so you can take action

Available via your medical practitioner

*Patient eligibility dependent on personal medical history, age and sex

Interested in ordering more than one disease? Order geneType™ Multi-Test.

The Multi-Risk suite of tests is for adults 40-85 years of age. At maximum, a woman would be eligible for eight diseases in the panel; a man would be eligible for seven. Starting at age 30, a patient may qualify for geneType’s™ cancer risk assessments only.

 

References

1. American Cancer Society Prostate Cancer Screening Recommendations. Accessed June 2022.

2. Rawla P. World J Oncol 2019;10:63–89.

Accredited For Compliance With NPAAC Standards And ISO 15189